Records containing: HIV-1-infection
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-05-18Phase 3b, Single Arm, Simplification Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen. (RALAM-II Study)
-
CLINICAL_TRIALS study record update · 2025-05-08An Umbrella Phase 1b, Open-label, Multi-Cohort Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Novel Antiretrovirals in Participants With HIV-1
-
CLINICAL_TRIALS study record update · 2025-05-07Registro Italiano Dei Pazienti Con Infezione da HIV-1 Con RESistenza Agli Inibitori Della Trascrittasi Inversa, Dell'InteGrasI e Della PrOteasi Virale (PRESTIGIO)
-
CLINICAL_TRIALS study record update · 2025-05-06Safety and Pharmacokinetics of the Combination Broadly Neutralizing Antibodies, 3BNC117-LS-J and 10-1074-LS-J, in Healthy American and African Adults
-
CLINICAL_TRIALS study record update · 2025-04-25Phase 1b Single Dose Clinical Trial of a Novel Long-Acting Bispecific Antibody in People With HIV to Inform Development for HIV Pre- and Post-Exposure Prophylaxis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-04-22IMPAACT 2016 - Evaluating a Group-Based Intervention to Improve Mental Health and Antiretroviral Therapy (ART) Adherence Among Youth Living With HIV in Low Resource Settings
-
CLINICAL_TRIALS study record update · 2025-04-15Implementation Science Research on PrEP Delivery and Costing Within Harm Reduction Services for People Who Use Drugs in Uganda
-
CLINICAL_TRIALS study record update · 2025-04-11Microbiome-based Stratification of Individuals at Risk of HIV-1 Acquisition, Chronic Clinical Complications, Antimicrobial Drug Resistance, and Unresponsiveness to Therapeutic HIV-1 Vaccination
-
CLINICAL_TRIALS study record update · 2025-04-08Short-term Effects of Methamphetamine Exposure on Residual Viral Transcription During Treated HIV Disease
-
CLINICAL_TRIALS study record update · 2025-04-02Opti-DOR: A Randomised, Phase 3 Non-inferiority Study of DOR/3TC/TDF Compared to DTG/TAF/FTC in Participants Infected With HIV-1 Starting First-line Antiretroviral Therapy
-
CLINICAL_TRIALS study record update · 2025-04-01Administration of the BCL-2 Antagonist, Venetoclax, to Promote Apoptosis of HIV-infected Cells and Reduce the Size of the HIV Reservoir: An Investigator-initiated Phase I/IIb Clinical Trial in People Living With HIV on Antiretroviral Therapy
-
CLINICAL_TRIALS study record update · 2025-03-24HIV-1 & Coronavirus-Coinfection in Europe: Morbidity & Risk Factors of COVID-19 in People Living With HIV
-
CLINICAL_TRIALS study record update · 2025-03-17HIV Transmission in the Era of Scaling up Access to Antiretroviral Therapy in Ethiopia
-
CLINICAL_TRIALS study record update · 2025-03-12Quantification of Antisense VIH-1 Transcripts and Comparison in Different Groups of Patients
-
CLINICAL_TRIALS study record update · 2025-02-27HIV Resistance, Molecular Epidemiology and New Treatment Strategies in the Eastern European Region and in Russia
-
CLINICAL_TRIALS study record update · 2025-02-21Dolutegravir in Pregnant HIV Mothers and Their Neonates
-
CLINICAL_TRIALS study record update · 2025-02-05ANRS EP69 BICTEVOIR : A Prospective Study to Determine the Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing bictégravir, Emtricitabine and ténofovir alafénamide
-
CLINICAL_TRIALS study record update · 2025-01-31A Randomized, Double-Blind, Placebo-Controlled Study of the Combination of Two Long-Acting Broadly Neutralizing Antibodies at ART Initiation in Adults Living With HIV-1 in Sub-Saharan Africa: The ACACIA Study
-
CLINICAL_TRIALS study record update · 2025-01-30Identification of Barriers and Facilitators of Implementation of the Out-of-Hospital Administration of the Long- Acting Combination Cabotegravir+Rilpivirina as an Optional Therapy in People Living With HIV From Spain.
-
CLINICAL_TRIALS study record update · 2025-01-27SYV: A Mental Health Intervention to Improve HIV Outcomes in Tanzanian Youth
-
CLINICAL_TRIALS study record update · 2025-01-16Improving HIV Prevention Among Adolescent Girls and Young Women (AGYW) in Uganda
-
CLINICAL_TRIALS study record update · 2024-12-24An Open-Label, Multi-Centre, Randomised, Switch Study to Evaluate the Virological Efficacy Over 96 Weeks Of 2-Drug Therapy With DTG/RPV FDC in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects Virologically Suppressed With Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Resistance Mutation K103N
-
CLINICAL_TRIALS study record update · 2024-12-16Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV
-
CLINICAL_TRIALS study record update · 2024-12-13Pharmacokinetic Interactions of Etonogestrel (ENG) Subdermal Implants with Long-Acting (LA) Cabotegravir (CAB-LA) and LA Rilpivirine (RPV-LA) (CARLA) in Participants of Reproductive Potential
-
CLINICAL_TRIALS study record update · 2024-12-13An Observational Post-Intervention Control Destination Cohort